Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct;94(10):4588-4590.
doi: 10.1002/jmv.27922. Epub 2022 Jun 16.

Dual impacts of the COVID-19 nonpharmaceutical interventions on other infectious diseases

Affiliations

Dual impacts of the COVID-19 nonpharmaceutical interventions on other infectious diseases

Yi-Qing Chen et al. J Med Virol. 2022 Oct.

Abstract

  1. 1.

    COVID nonpharmaceutical interventions (NPIs) impacted on other infectious diseases.

  2. 2.

    The impacts on 36 infectious diseases in China were calculated.

  3. 3.

    COVID NPIs increased the incidences of some infectious diseases.

  4. 4.

    COVID NPIs reduced the incidences of some other infectious diseases.

  5. 5.

    The impacts were calculated with optimized methods.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Integration of three previous opinions shown by blue arrows into our statistics‐supported opinion.
Figure 2
Figure 2
Changes in the relative incidences (RIs) in red lines and their first‐order differences (FoDs) in blue bars of 36 infectious diseases in China in 2011−2021. *p < 0.05, **p < 0.01, red asterisks significant increase compared with the years 2011−2019, and black asterisks significant decline compared with the years 2011−2019. The asterisks near the abscissa are for the blue bars, and the asterisks near the red squares are for the red squares.

References

    1. Islam N, Sharp SJ, Chowell G, et al. Physical distancing interventions and incidence of coronavirus disease 2019: natural experiment in 149 countries. BMJ. 2020;370:m2743. 10.1136/bmj.m2743 - DOI - PMC - PubMed
    1. Crane MA, Popovic A, Panaparambil R, Stolbach AI, Romley JA, Ghanem KG. Reporting of infectious diseases in the United States during the COVID‐19 pandemic. Clin Infect Dis. 2022;74:901‐904. 10.1093/cid/ciab529 - DOI - PMC - PubMed
    1. de Souza Luna LK, Perosa DAH, Conte DD, et al. Different patterns of Influenza A and B detected during early stages of COVID‐19 in a university hospital in Sao Paulo. J Infect. 2020;81(2):e104‐e105. 10.1016/j.jinf.2020.05.036 - DOI - PMC - PubMed
    1. Chen JM, Chen YQ, Sun YX. Control of COVID‐19 in China likely reduced the burden of multiple other infectious diseases. J Infect. 2022;84(4):579‐613. 10.1016/j.jinf.2022.01.001 - DOI - PMC - PubMed
    1. Ye Q, Liu H. Impact of non‐pharmaceutical interventions during the COVID‐19 pandemic on common childhood respiratory viruses—an epidemiological study based on hospital data. Microbes Infect. 2022;24(1):104911. 10.1016/j.micinf.2021.104911 - DOI - PMC - PubMed

Publication types